Tag: Diabetes: Type II
Lower CVD Mortality for Metformin Versus Sulfonylureas
Large analysis found up to 40 percent lower risk of heart disease mortality versus sulfonylureas
Metformin May Reduce Cancer Mortality Risk
Older women with diabetes and cancer taking metformin saw an increase in survival
CV Risk Not Significantly Different for GLP-1 Receptor Agonists
Findings based on large study in real-world, head-to-head comparison of other drugs
Exenatide Twice Daily Deemed Efficacious Across BMI Ranges
Significant weight loss with exenatide across BMI ranges; weight increased with comparators
Diabetes Weight Loss Diets Improve Emotional Measures
Findings regardless of whether diet was low or high in carbohydrates
ACC: More Evidence of Long-Term Benefits of Bariatric Surgery
After five years, more patients in surgery group had lower blood glucose than in medication-only group
Long-Term Weight Loss Cuts Diabetes-Related Brain Changes
10-year weight loss intervention tied to lower white matter hyperintensity volume
ENDO: ‘Paleo’ Diet May Benefit Heart Health Post Menopause
Trendy eating plan may cut cholesterol, disease risks in postmenopausal women
ENDO: Hypothyroidism Ups T2DM Odds Even With Low-Normal TSH
Higher free thyroxine levels associated with reduced diabetes risk
Pioglitazone Linked to Increased Risk of Bladder Cancer
Duration- and dose-response associations for pioglitazone; no correlation for rosiglitazone
